NorthWest Biotherapeutics Inc (NWBO)

[VuBru]

You are probably correct if you mean by "data are bad" that the study failed its original primary PFS and/or secondary OS endpoints. That would not come as a surprise to most people here. However, those are no longer the official study outcomes (now it is historical controls, and results for these outcomes are all but certain to be positive). I agree that the motivation for announcing results through a publication has to be to provide adequate context for the complexities of the trial and how this impacted on the analytic approach and the study results.